rs376046736
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020686.6(ABAT):c.816+7C>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000556 in 1,614,078 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_020686.6 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ABAT | NM_020686.6 | c.816+7C>A | splice_region_variant, intron_variant | ENST00000268251.13 | NP_065737.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ABAT | ENST00000268251.13 | c.816+7C>A | splice_region_variant, intron_variant | 1 | NM_020686.6 | ENSP00000268251 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00303 AC: 461AN: 152172Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000847 AC: 213AN: 251438Hom.: 2 AF XY: 0.000500 AC XY: 68AN XY: 135890
GnomAD4 exome AF: 0.000291 AC: 425AN: 1461788Hom.: 2 Cov.: 32 AF XY: 0.000237 AC XY: 172AN XY: 727196
GnomAD4 genome AF: 0.00310 AC: 472AN: 152290Hom.: 1 Cov.: 33 AF XY: 0.00295 AC XY: 220AN XY: 74458
ClinVar
Submissions by phenotype
Gamma-aminobutyric acid transaminase deficiency Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 05, 2015 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 28, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at